Biocytogen inks non-exclusive VHH antibody licensing deal with Qilu Pharma
Biocytogen Pharmaceuticals (Beijing) entered a non-exclusive licensing agreement with Qilu Pharmaceutical covering a fully human VHH antibody molecule.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.